Deconstructing endothelial dysfunction: soluble guanylyl cyclase oxidation and the NO resistance syndrome

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

Furchgott, R. F., & Zawadzki, J. V. (1980) · Nature · doi:10.1038/288373a0 · Cited by 12,064 · see citing works

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704 · see citing works

Arginine metabolism: nitric oxide and beyond

WU, G., & MORRIS, S. M. (1998) · Biochemical Journal · doi:10.1042/bj3360001 · Cited by 2,811 · see citing works

Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation

Cosby, K., Partovi, K. S., Crawford, J. H., Patel, R. P., Reiter, C. D., Martyr, S., Yang, B. K., Waclawiw, M. A., Zalos, G., Xu, X., et al. (2003) · Nature Medicine · doi:10.1038/nm954 · Cited by 1,807 · see citing works

S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds.

Stamler, J. S., Simon, D. I., Osborne, J. A., Mullins, M. E., Jaraki, O., Michel, T. M., Singel, D. J., & Loscalzo, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.444 · Cited by 1,471 · see citing works

Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease

Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330 · see citing works

Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical.

Ignarro, L. J., Byrns, R. E., Buga, G. M., & Wood, K. S. (1987) · Circulation Research · doi:10.1161/01.res.61.6.866 · Cited by 1,164 · see citing works

Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease

Reiter, C. D., Wang, X., Tanus-Santos, J. E., et al. (2002) · Nature Medicine · doi:10.1038/nm799 · Cited by 1,097 · see citing works

Dysregulated Arginine Metabolism, Hemolysis-Associated Pulmonary Hypertension, and Mortality in Sickle Cell Disease

Morris, C. R. (2005) · JAMA · doi:10.1001/jama.294.1.81 · Cited by 762 · see citing works

S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide

Adachi, T. K., Weisbrod, R. M., Pimentel, D. R., Ying, J., Sharov, V. S., Schöneich, C., & Cohen, R. A. (2004) · Nature Medicine · doi:10.1038/nm1119 · Cited by 662 · see citing works

Arginase Reciprocally Regulates Nitric Oxide Synthase Activity and Contributes to Endothelial Dysfunction in Aging Blood Vessels

Berkowitz, D. E., White, R., Li, D., Minhas, K. M., Cernetich, A., Kim, S., Burke, S., Shoukas, A. A., Nyhan, D., Champion, H. C., et al. (2003) · Circulation · doi:10.1161/01.cir.0000092948.04444.c7 · Cited by 486 · see citing works

Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels

Stasch, J., Schmidt, P. M., Nedvetsky, P. I., Nedvetskaya, T. Y., Kumar, A. H. S., Meurer, S., Deile, M., Taye, A., Knorr, A., Lapp, H., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28371 · Cited by 456 · see citing works

Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis.

Quyyumi, A. A., Dakak, N., Andrews, N. P., Husain, S., Arora, S., Gilligan, D. M., Panza, J. A., & Cannon, R. O. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117852 · Cited by 444 · see citing works

Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease

Aslan, M., Ryan, T. M., Adler, B., Townes, T. M., Parks, D. A., Thompson, J. A., Tousson, A., Gladwin, M. T., Patel, R. P., Tarpey, M. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221292098 · Cited by 391 · see citing works

Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin

Minneci, P. C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25040 · Cited by 329 · see citing works

Divergent Nitric Oxide Bioavailability in Men and Women With Sickle Cell Disease

Gladwin, M. T., Schechter, A. N., Ognibene, F. P., Coles, W. A., Reiter, C. D., Schenke, W. H., Csákó, G., Waclawiw, M. A., Panza, J. A., & Cannon, R. O. (2003) · Circulation · doi:10.1161/01.cir.0000044943.12533.a8 · Cited by 270 · see citing works

Hemoglobin and the Paracrine and Endocrine Functions of Nitric Oxide

Schechter, A. N., & Gladwin, M. T. (2003) · New England Journal of Medicine · doi:10.1056/nejmcibr023045 · Cited by 247 · see citing works

Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse

Kaul, D. K., Liu, X.-D., Fabry, M. E., & Nagel, R. L. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.6.h1799 · Cited by 122 · see citing works

Sickle cell anemia is associated with reduced nitric oxide bioactivity in peripheral conduit and resistance vessels

Eberhardt, R. T., McMahon, L. C., Duffy, S. J., Steinberg, M. H., Perrine, S. P., Loscalzo, J., Coffman, J. D., & Vita, J. A. (2003) · American Journal of Hematology · doi:10.1002/ajh.10387 · Cited by 113 · see citing works

Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice

Kaul, D. K., Liu, X.-D., Chang, H.-Y., Nagel, R. L., & Fabry, M. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21633 · Cited by 108 · see citing works

Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease

Nath, K. A., Shah, V. H., Haggard, J. J., Croatt, A. J., Smith, L. A., Hebbel, R. P., & Katušić, Z. S. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.6.r1949 · Cited by 94 · see citing works

eNOS Gene Therapy Exacerbates Hepatic Ischemia-Reperfusion Injury in Diabetes

Elrod, J. W., Duranski, M. R., Langston, W., Greer, J. J. M., Tao, L., Dugas, T. R., Kevil, C. G., Champion, H. C., & Lefer, D. J. (2006) · Circulation Research · doi:10.1161/01.res.0000231306.03510.77 · Cited by 75 · see citing works

Nitrate tolerance and the links with endothelial dysfunction and oxidative stress

Fayers, K. E., Cummings, M. H., Shaw, K. M., & Laight, D. W. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01946.x · Cited by 32 · see citing works

Sickle-cell disease

Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504 · see citing works

Pathophysiology of Sickle Cell Disease

Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813 · see citing works

Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease

Stasch, J., Pacher, P., & Evgenov, O. V. (2011) · Circulation · doi:10.1161/circulationaha.110.981738 · Cited by 602 · see citing works

Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation

Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541 · see citing works

Pulmonary Complications of Sickle Cell Disease

Gladwin, M. T., & Vichinsky, E. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0804411 · Cited by 470 · see citing works

Sickle Cell Anemia, the First Molecular Disease: Overview of Molecular Etiology, Pathophysiology, and Therapeutic Approaches

Steinberg, M. H. (2008) · The Scientific World JOURNAL · doi:10.1100/tsw.2008.157 · Cited by 295 · see citing works

Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure

Follmann, M., Ackerstaff, J., Redlich, G., Wunder, F., Lang, D. H., Kern, A., Fey, P., Griebenow, N., Kroh, W., Becker‐Pelster, E., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00449 · Cited by 208 · see citing works

NO-Independent, Haem-Dependent Soluble Guanylate Cyclase Stimulators

Stasch, J., & Hobbs, A. J. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-68964-5_13 · Cited by 205 · see citing works

The Chemistry and Biology of Soluble Guanylate Cyclase Stimulators and Activators

Follmann, M., Griebenow, N., Hahn, M. G., Hartung, I., Mais, F., Mittendorf, J., Schäfer, M., Schirok, H., Stasch, J., Stoll, F., et al. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201302588 · Cited by 200 · see citing works

Soluble Guanylate Cyclase Stimulators and Activators

Sandner, P., Zimmer, D. P., Milne, G. T., Follmann, M., Hobbs, A. J., & Stasch, J. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_197 · Cited by 183 · see citing works

Pulmonary Complications of Sickle Cell Disease

Miller, A. C., & Gladwin, M. T. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-2082ci · Cited by 182 · see citing works

Pharmacology and Therapeutics of Bronchodilators Revisited

Matera, M. G., Page, C. P., Calzetta, L., Rogliani, P., & Cazzola, M. (2019) · Pharmacological Reviews · doi:10.1124/pr.119.018150 · Cited by 175 · see citing works

Cardiovascular complications and risk of death in sickle-cell disease

Gladwin, M. T. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00647-4 · Cited by 164 · see citing works

NO- and Haem-Independent Soluble Guanylate Cyclase Activators

Schmidt, H. H. H. W., Schmidt, P. M., & Stasch, J. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-68964-5_14 · Cited by 159 · see citing works

Soluble guanylate cyclase: a potential therapeutic target for heart failure

Gheorghiade, M., Marti, C. N., Sabbah, H. N., Roessig, L., Greene, S. J., Böhm, M., Burnett, J. C. J., Campia, U., Cleland, J. G. F., Collins, S. P., et al. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9323-1 · Cited by 156 · see citing works

Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase

Soro‐Paavonen, A., Zhang, W.-Z., Venardos, K. M., Coughlan, M. T., Harris, E., Tong, D., Brasacchio, D., Paavonen, K., Chin-Dusting, J. P. F., Cooper, M. E., et al. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e328335043e · Cited by 109 · see citing works

Soluble GC stimulators and activators: Past, present and future

Sandner, P., Follmann, M., Becker‐Pelster, E., Hahn, M. G., Meier, C., Freitas, C., Roessig, L., & Stasch, J. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15698 · Cited by 105 · see citing works

Aldosterone Increases Oxidant Stress to Impair Guanylyl Cyclase Activity by Cysteinyl Thiol Oxidation in Vascular Smooth Muscle Cells

Maron, B. A., Zhang, Y., Handy, D. E., Beuve, A. V., Tang, S., Loscalzo, J., & Leopold, J. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809460200 · Cited by 101 · see citing works

Contemporary Approaches to Modulating the Nitric Oxide–cGMP Pathway in Cardiovascular Disease

Kraehling, J. R., & Sessa, W. C. (2017) · Circulation Research · doi:10.1161/circresaha.117.303776 · Cited by 98 · see citing works

Vascular nitric oxide resistance in type 2 diabetes

Bahadoran, Z., Mirmiran, P., Kashfi, K., & Ghasemi, A. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05935-5 · Cited by 90 · see citing works

Nitric Oxide and Heat Shock Protein 90 Activate Soluble Guanylate Cyclase by Driving Rapid Change in Its Subunit Interactions and Heme Content

Ghosh, A., Stasch, J., Papapetropoulos, A., & Stuehr, D. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.559393 · Cited by 75 · see citing works

Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma

Ghosh, A., Koziol‐White, C. J., Asosingh, K., Cheng, G., Ruple, L. M., Groneberg, D., Friebe, A., COMHAIR, S. A. A., Stasch, J., Panettieri, R. A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524398113 · Cited by 70 · see citing works

Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY 1101042)

Hahn, M. G., Lampe, T. F. J., Sheikh, S. E., Griebenow, N., Woltering, E., Schlemmer, K., Dietz, L., Gerisch, M., Wunder, F., Becker‐Pelster, E., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c02154 · Cited by 69 · see citing works

Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation‐induced degradation

Hoffmann, L., Schmidt, P., Keim, Y., Schaefer, S., Schmidt, H. H. H. W., & Stasch, J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00263.x · Cited by 64 · see citing works

Nitric Oxide Signaling

Underbakke, E. S., Sürmeli, N. B., Smith, B. C., Wynia‐Smith, S. L., & Marletta, M. A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-08-097774-4.00320-x · Cited by 51 · see citing works

Maturation, inactivation, and recovery mechanisms of soluble guanylyl cyclase

Stuehr, D. J., Misra, S., Dai, Y., & Ghosh, A. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100336 · Cited by 50 · see citing works

Heme-Dependent and Independent Soluble Guanylate Cyclase Activators and Vasodilation

Priviero, F. B. M., & Webb, R. C. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181eb4e75 · Cited by 49 · see citing works

Arterial Stiffness Impairment in Sickle Cell Disease Associated With Chronic Vascular Complications

Ranque, B., Menet, A., Boutouyrie, P., Diop, I. B., Kingué, S., Diarra, M., N’Guetta, R., Diallo, D. A., Diop, S., Diagne, I., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.021015 · Cited by 48 · see citing works

Spironolactone treatment attenuates vascular dysfunction in type 2 diabetic mice by decreasing oxidative stress and restoring NO/GC signaling

Silva, M. A. B., Bruder-Nascimento, T. B., Cáu, S. B. D. A., Alves-Lopes, R., Mestriner, F., Fais, R. S., Touyz, R. M., & Tostes, R. C. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00269 · Cited by 47 · see citing works

Dimerization Region of Soluble Guanylate Cyclase Characterized by Bimolecular Fluorescence Complementation in Vivo

Rothkegel, C., Schmidt, P. M., Atkins, D.-J., Hoffmann, L. S., Schmidt, H. H. H. W., Schröder, H., & Stasch, J. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.036368 · Cited by 45 · see citing works

Nitric oxide: To be or not to be an endocrine hormone?

Bahadoran, Z., Carlström, M., Mirmiran, P., & Ghasemi, A. (2020) · Acta Physiologica · doi:10.1111/apha.13443 · Cited by 42 · see citing works

Platelet hyperaggregability in high-fat fed rats: A role for intraplatelet reactive-oxygen species production

Monteiro, P. F., Morganti, R. P., Delbin, M. A., Calixto, M. C., Pires, M. E. L., Marcondes, S., Zanesco, A., & Antunes, E. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-5 · Cited by 39 · see citing works

Fluorescence Dequenching Makes Haem-Free Soluble Guanylate Cyclase Detectable in Living Cells

Hoffmann, L. S., Schmidt, P. M., Keim, Y., Hoffmann, C., Schmidt, H. H. H. W., & Stasch, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023596 · Cited by 39 · see citing works

The sGC stimulator riociguat inhibits platelet function in washed platelets but not in whole blood

Reiss, C., Викторович, М. И., Bischoff, V., Subramanian, H., Kehrer, L., Friebe, A., Stasch, J., Gambaryan, S. P., & Walter, U. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13286 · Cited by 36 · see citing works

Platelet Oxidative Stress and its Relationship with Cardiovascular Diseases in Type 2 Diabetes Mellitus Patients

Haouari, M. E. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666171005114456 · Cited by 36 · see citing works

Nitric Oxide–Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease

Potoka, K. P., Wood, K. C., Baust, J., Bueno, M., Hahn, S. A., Vanderpool, R. R., Bachman, T. N., Mallampalli, G. M., Osei-Hwedieh, D. O., Schrott, V. M., et al. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0292oc · Cited by 35 · see citing works

Insight into the Rescue of Oxidized Soluble Guanylate Cyclase by the Activator Cinaciguat

Sürmeli, N. B., & Marletta, M. A. (2012) · ChemBioChem · doi:10.1002/cbic.201100809 · Cited by 36 · see citing works

Endogenous Hemoprotein-Dependent Signaling Pathways of Nitric Oxide and Nitrite

Dent, M. R., DeMartino, A. W., Tejero, J., & Gladwin, M. T. (2021) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.1c01048 · Cited by 35 · see citing works

Thiol-catalyzed formation of NO-ferroheme regulates intravascular NO signaling

DeMartino, A. W., Poudel, L., Dent, M. R., Chen, X., Xu, Q., Gladwin, B., Tejero, J., Basu, S., Alipour, E., Jiang, Y., et al. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01413-3 · Cited by 35 · see citing works

Runcaciguat, a novel soluble guanylate cyclase activator, shows renoprotection in hypertensive, diabetic, and metabolic preclinical models of chronic kidney disease

Benardeau, A. M., Kahnert, A., Schomber, T., Meyer, J., Pavkovic, M., Kretschmer, A., Lawrenz, B., Hartmann, E., Mathar, I., Hueser, J., et al. (2021) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-021-02149-4 · Cited by 35 · see citing works

Therapeutics Targeting of Dysregulated Redox Equilibrium and Endothelial Dysfunction

Risbano, M. G., & Gladwin, M. T. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-38664-0_13 · Cited by 32 · see citing works

The trials and hopes for drug development in sickle cell disease

Ataga, K. I., & Stocker, J. W. (2015) · British Journal of Haematology · doi:10.1111/bjh.13548 · Cited by 32 · see citing works

Associations between endothelial dysfunction and clinical and laboratory parameters in children and adolescents with sickle cell anemia

Teixeira, R., Terse-Ramos, R., Ferreira, T. A., Machado, V. R., Perdiz, M. I., Lyra, I. M., Nascimento, V. M. L., Boa‐Sorte, N., Andrade, B. B., & Ladeia, A. M. T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184076 · Cited by 32 · see citing works

Ambient air pollution and sickle cell disease-related emergency department visits in Atlanta, GA

Blumberg, A. H., Ebelt, S., Liang, D., Morris, C. R., & Sarnat, J. A. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109292 · Cited by 31 · see citing works

Sulfaphenazole treatment restores endothelium-dependent vasodilation in diabetic mice

Elmi, S., Sallam, N. A., Rahman, M. M., Teng, X., Hunter, A. L., Moien‐Afshari, F., Khazaei, M., Granville, D. J., & Laher, I. (2007) · Vascular Pharmacology · doi:10.1016/j.vph.2007.09.001 · Cited by 31 · see citing works

Blood Pressure-Independent Effect of Long-Term Treatment with the Soluble Heme-Independent Guanylyl Cyclase Activator HMR1766 on Progression in a Model of Noninflammatory Chronic Renal Damage

Benz, K., Orth, S. R., Simonaviciene, A., Linz, W., Schindler, U., Rütten, H., & Amann, K. (2007) · Kidney & Blood Pressure Research · doi:10.1159/000104091 · Cited by 29 · see citing works

Modulation of Soluble Guanylate Cyclase for the Treatment of Erectile Dysfunction

Lasker, G. F., Pankey, E. A., & Kadowitz, P. J. (2013) · Physiology · doi:10.1152/physiol.00001.2013 · Cited by 29 · see citing works

The proverbial chicken or the egg? Dissection of the role of cell-free hemoglobin versus reactive oxygen species in sickle cell pathophysiology

Krajewski, M. L., Hsu, L. L.-Y., & Gladwin, M. T. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00499.2008 · Cited by 28 · see citing works

Chronic Activation of Heme Free Guanylate Cyclase Leads to Renal Protection in Dahl Salt-Sensitive Rats

Hoffmann, L. S., Kretschmer, A., Lawrenz, B., Hocher, B., & Stasch, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145048 · Cited by 27 · see citing works

The molecular mechanism of heme loss from oxidized soluble guanylate cyclase induced by conformational change

Pan, J., Zhang, X., Yuan, H., Xu, Q., Zhang, H., Zhou, Y., Huang, Z., & Tan, X. (2016) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2016.02.012 · Cited by 26 · see citing works

Vasculopathy in Sickle Cell Disease: From Red Blood Cell Sickling to Vascular Dysfunction

Nader, É., Conran, N., Romana, M., & Connes, P. (2021) · Comprehensive physiology · doi:10.1002/cphy.c200024 · Cited by 35 · see citing works

Therapeutics Targeting of Dysregulated Redox Equilibrium and Endothelial Dysfunction

Risbano, M. G., & Gladwin, M. T. (2013) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-662-45805-1_13 · Cited by 32 · see citing works

Mechanisms and Clinical Complications of Hemolysis in Sickle Cell Disease and Thalassemia

Kato, G. J., & Gladwin, M. T. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.016 · Cited by 22 · see citing works

Tracing the path of inhaled nitric oxide: Biological consequences of protein nitrosylation

Bhatia, V., Elnagary, L., & Dakshinamurti, S. (2020) · Pediatric Pulmonology · doi:10.1002/ppul.25201 · Cited by 23 · see citing works

Chronic limb-threatening ischemia could benefit from growth hormone therapy for wound healing and limb salvage

Caicedo, D., Devesa, P., Arce, V. M., Requena, J., & Devesa, J. (2017) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944717745494 · Cited by 21 · see citing works

Is Nitrite the Circulating Endocrine Effector of Remote Ischemic Preconditioning?

Corti, P., & Gladwin, M. T. (2014) · Circulation Research · doi:10.1161/circresaha.114.303960 · Cited by 20 · see citing works

Regulation of sGC <i>via</i> hsp90, Cellular Heme, sGC Agonists, and NO: New Pathways and Clinical Perspectives

Ghosh, A., & Stuehr, D. J. (2017) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2016.6690 · Cited by 19 · see citing works

New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension

Vakalopoulos, A., Wunder, F., Hartung, I. V., Redlich, G., Jautelat, R., Buchgraber, P., Hassfeld, J., Gromov, A., Lindner, N., Bierer, D. E., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c02082 · Cited by 19 · see citing works

The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats

Reinke, Y., Groß, S., Eckerle, L. G., Hertrich, I., Busch, M., Busch, R., Riad, A., Rauch, B. H., Stasch, J., Dörr, M., et al. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.09.022 · Cited by 19 · see citing works

Why Should Growth Hormone (GH) Be Considered a Promising Therapeutic Agent for Arteriogenesis? Insights from the GHAS Trial

Caicedo, D., Devesa, P., Álvarez, C. V., & Devesa, J. (2020) · Cells · doi:10.3390/cells9040807 · Cited by 19 · see citing works

A Prospective Appraisal of Pulmonary Hypertension in Children With Sickle Cell Disease

Sedrak, A., Rao, S. P., Miller, S. T., Hekmat, V., & Rao, M. (2009) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e31818e5343 · Cited by 19 · see citing works

New approaches to the treatment of nephropathy in diabetes

Thomas, M. C., & Groop, P. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.591785 · Cited by 17 · see citing works

Induction of PDE5 and de-sensitization to endogenous NO signaling in a systemic resistance artery under altered blood flow

Zhang, H., Pakeerappa, P. N., Lee, H. J., & Fisher, S. A. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.03.025 · Cited by 13 · see citing works

Hydralazine does not Ameliorate Nitric Oxide Resistance in Chronic Heart Failure

Chirkov, Y. Y., Sciscio, M. D., Sverdlov, A. L., Leslie, S., Sage, P. R., & Horowitz, J. D. (2010) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-010-6233-0 · Cited by 12 · see citing works

Soluble Guanylate Cyclase

Hobbs, A. J., & Stasch, J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-373866-0.00009-5 · Cited by 12 · see citing works

Hemoglobin resident in the lung epithelium is protective for smooth muscle soluble guanylate cyclase function

Sumi, M. P., Tupta, B., Roychowdhury, S., COMHAIR, S. A. A., Asosingh, K., Stuehr, D. J., ERZURUM, S. C., & Ghosh, A. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102717 · Cited by 11 · see citing works

Endothelial Chronic Destructive Pulmonary Disease (E-CDPD): Is Endothelial Apoptosis a Subphenotype or Prequel to COPD?

Chandra, D., Sciurba, F. C., & Gladwin, M. T. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0758ed · Cited by 11 · see citing works

Nitric oxide and thiols: Chemical biology, signalling paradigms and vascular therapeutic potential

Dent, M. R., & DeMartino, A. W. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16274 · Cited by 10 · see citing works

A Phase II study of avenciguat, a novel soluble guanylate cyclase activator, in patients with systemic sclerosis: Study design and rationale of the VITALISScE™ study

Khanna, D., de Vries‐Bouwstra, J., Hoffmann‐Vold, A., Kuwana, M., Low, A. H. L., Proudman, S., Flack, M., Kukreja, A., Fagan, N. M., & Distler, O. (2024) · Journal of Scleroderma and Related Disorders · doi:10.1177/23971983241291923 · Cited by 9 · see citing works

Vasculopathy in Sickle Cell Disease: From Red Blood Cell Sickling to Vascular Dysfunction

Nader, É., Conran, N., Romana, M., & Connes, P. (2021) · Comprehensive physiology · doi:10.1002/j.2040-4603.2021.tb00164.x · Cited by 8 · see citing works

Soluble Guanylate Cyclase Activation With Cinaciguat

Hingorany, S., & Frishman, W. H. (2010) · Cardiology in Review · doi:10.1097/crd.0b013e3181fc1c10 · Cited by 7 · see citing works

Dental Pulp Inflammation Initiates the Occurrence of Mast Cells Expressing the α1 and β1 Subunits of Soluble Guanylyl Cyclase

Korkmaz, Y., Plomann, M., Puladi, B., Kaya, A. D., Bloch, W., & Deschner, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24020901 · Cited by 6 · see citing works

Adenylyl Cyclase Isoform 6 in the Pulmonary Artery Is Inhibited by Hypoxia via Cysteine Nitrosylation

Maghsoudi, S., Bhatia, V., Hinton, M., Singh, N., Khan, M. W., Chelikani, P., & Dakshinamurti, S. (2024) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2023-0447oc · Cited by 6 · see citing works

Chemie und Biologie der Stimulatoren und Aktivatoren der löslichen Guanylatcyclase

Follmann, M., Griebenow, N., Hahn, M. G., Hartung, I. V., Mais, F., Mittendorf, J., Schäfer, M., Schirok, H., Stasch, J., Stoll, F., et al. (2013) · Angewandte Chemie · doi:10.1002/ange.201302588 · Cited by 5 · see citing works

Nitric oxide augments signaling for contraction in hypoxic pulmonary arterial smooth muscle—Implications for hypoxic pulmonary hypertension

Hinton, M., Thliveris, J. A., Hatch, G. M., & Dakshinamurti, S. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1144574 · Cited by 5 · see citing works

NO-cGMP Signaling in Endothelial Function of the Healthy and Inflamed Dental Pulp

Korkmaz, Y., Kollmar, T., Schultheis, J. F., Ziskoven, P. C., Müller-Heupt, L. K., & Deschner, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010057 · Cited by 4 · see citing works

Soluble guanylate cyclase in NO signaling transduction

Pan, J., Zhong, F., & Tan, X. (2013) · Reviews in Inorganic Chemistry · doi:10.1515/revic-2013-0011 · Cited by 3 · see citing works

PATHOPHYSIOLOGY OF HEMOGLOBIN AND ITS DISORDERS

Steinberg, M. H. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.012 · Cited by 2 · see citing works

Assessing the atria in pediatric sickle cell disease: Beyond the dilation

Loar, R. W., George, A., Varghese, N. P., Liu, A. M., Colquitt, J. L., & Pignatelli, R. H. (2020) · Echocardiography · doi:10.1111/echo.14956 · Cited by 2 · see citing works

[Hemostasis alterations in sickle cell syndrome].

Higuera, D., Bravo, M. N. A., & Guerrero, B. (2014) · PubMed · Cited by 2 · see citing works

Soluble guanylate cyclase: a potential therapeutic target for heart

Butler, J.-P. S. (2013) · Cited by 1 · see citing works

Organic and dietary nitrates, inorganic nitrite, nitric oxide donors, and soluble guanylate cyclase stimulation

O’Gallagher, K., & Webb, A. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91391-1.00051-0

Nitric oxide resistance in type 2 diabetes: Potential implications of HNO donors

Bahadoran, Z., Mirmiran, P., Kashfi, K., & Ghasemi, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-13342-8.00018-1

Cytoglobin-dependent NO-sGC-cGMP signaling regulates ventricular morphogenesis and diastolic functionPreprint

Clark, A. A., Hejlesen, R., Weng, T.-T., Iqbal, M., Bruce, A., & Corti, P. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.13.711730

Spécificité de la fonction microvasculaire chez les porteurs du trait drépanocytaire : Effets de l'activité physique en environnement chaud

Reminy, K. (2021) · doi:10.70675/e6647604z3ce9z4fb1zae18ze721ff13425c

Étude du rôle de la protéine S et du potentiel thérapeutique d’un anticorps à domaine unique potentialisant son activité dans la drépanocytose

Auditeau, C. (2025) · theses.fr (ABES) · doi:10.70675/4c79be71zf414z4e8ez8564z8c7efc3950f1

BindingDB Entry 50000054: Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure.

BindingDB (2019) · UC San Diego · doi:10.7270/q2cz399k

Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels

Stasch, J., Schmidt, P. M., Nedvetsky, P. I., Nedvetskaya, T. Y., Kumar, A. H. S., Meurer, S., Deile, M., Taye, A., Knorr, A., Lapp, H., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28371 · Cited by 456 · see citing works

Haeme Oxidised Soluble Guanylate Cyclase: A Novel Target for Vasorelaxation

Schmidt, H. H. H. W., Luk, J., Favaloro, J. L., Stasch, J.-P., & Kemp‐Harper, B. K. (2007) · Heart Lung and Circulation · doi:10.1016/j.hlc.2007.06.407

Abstract P093: Cytochrome B5 Reductase 3 And Xanthine Oxidase Coordinately Regulate Soluble Guanylyl Cyclase Physiological Redox State

Durgin, B. G., Schmidt, H. M., Hahn, S. A., & Straub, A. C. (2020) · Hypertension · doi:10.1161/hyp.76.suppl_1.p093

Abstract P139: Cytochrome B5 Reductase 3 Biases Activation of Soluble Guanylyl Cyclase in Resistance Arteries

Durgin, B. G., Hahn, S. A., de Cabo, R., & Straub, A. C. (2019) · Hypertension · doi:10.1161/hyp.74.suppl_1.p139

Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation

Hoffmann, L. S., Schmidt, P. M., Keim, Y., Schaefer, S., Schmidt, H. H. H. W., & Stasch, J. (2009) · BMC Pharmacology · doi:10.1186/1471-2210-9-s1-p26 · Cited by 7 · see citing works